Log In
BCIQ
Print this Print this
 

NGM313

  Manage Alerts
Collapse Summary General Information
Company NGM Biopharmaceuticals Inc.
DescriptionHumanized mAb activating the klotho beta (KLB)-fibroblast growth factor (FGF) receptor 1c isoform (FGFR1c) complex
Molecular Target Fibroblast growth factor (FGF) receptor 1c isoform (FGFR1c) ; Klotho beta (KLB)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard Indication Metabolic (unspecified)
Indication DetailsTreat metabolic diseases
Regulatory Designation
PartnerMerck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today